Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2023-07-06 00:00:00 ET · period of report 2023-07-05 · accession 0001209191-23-041611 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-06 | 2023-07-05 | FATE | Powl Brian T. | Chief Commercial Off | S - Sale | $4.87 | -3,854 | 41.1K | -9% | -$18.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-05 | S | D | 3,854 | $4.87 | 41,146 | D | — | — | (F2) Represents the weighted average sale price of the shares sold from $4.82 to $4.94 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth this footnote. |